{"text_format":"3","workbook":"xls","n_sheets":3,"sheets":["Sheet1","Sheet2","Sheet3"],"not_rendered":{"external_links":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet1","index":0,"n_rows":16,"n_cols":4,"rows_kept":16,"flags":["formulas_cached_only"]}
[null,"< 12 m survivors","> 12 m survivors","p value"]
["Gender (M : F)","43 : 17 (2.53)","73 : 35 (2.09)","ns"]
["Mean age at NM diagnosis, mean (SD)","21.7 (8)","18.6 (5)","< 0.01"]
["Children : Adult","33 : 28 (1.18)","52 : 55 (0.95)","ns"]
["Mean duration to NM diagnosis, mean (SD)","13.5 (4.1)","22.5 (3.7)","< 0.0001"]
["Concurrent NM, N (%)","20 (32.79%)","35 (32.71%)","ns"]
["Medulloblastoma, N (%)","23 (37.70%)","42 (39.25%)","ns"]
["GCTs, N (%)","6 (9.84%)","23 (21.50%)","< 0.05"]
["Glioma, N (%)","11 (18.03%)","17 (15.89%)","ns"]
["Ependymoma, N (%)","5 (8.20%)","8 (7.48%)","ns"]
["PPTs, N (%)","6 (9.84%)","4 (3.74%)","< 0.01"]
["LM, N (%)","17 (27.87%)","60 (56.07%)","< 0.001"]
["Ventricular system, N (%)","11 (18.03%)","25 (23.36%)","ns"]
["Cerebrospinal parechyma, N (%)","4 (6.56%)","18 (16.82%)","ns"]
["OP alone: Comprehensive treatment (OP+CT+RT)","4 : 8 (0.5)","2 : 10 (0.2)","< 0.05"]
["M, male; F, female; OP, operation; CT, chemotherapy; RT, radiotherapy."]

{"sheet":"Sheet2","index":1,"n_rows":0,"n_cols":0,"rows_kept":0,"flags":["formulas_cached_only"]}

{"sheet":"Sheet3","index":2,"n_rows":0,"n_cols":0,"rows_kept":0,"flags":["formulas_cached_only"]}